{"id":"https://openalex.org/W1996109366","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","title":"P2-14-01: Race, Response to Chemotherapy, and Outcome within Clinical Breast Cancer Subtypes.","display_name":"P2-14-01: Race, Response to Chemotherapy, and Outcome within Clinical Breast Cancer Subtypes.","publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W1996109366","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","mag":"1996109366"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs11-p2-14-01","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088336504","display_name":"JR Tichy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JR Tichy","raw_affiliation_strings":["1UNC, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073382740","display_name":"AM Deal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"AM Deal","raw_affiliation_strings":["1UNC, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000235117","display_name":"CK Anders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CK Anders","raw_affiliation_strings":["1UNC, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041777150","display_name":"LA Carey","orcid":"https://orcid.org/0000-0003-2388-4649","observed_orcids":["https://orcid.org/0000-0003-2388-4649"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LA Carey","raw_affiliation_strings":["1UNC, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"24_Supplement","first_page":"P2","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.824999988079071},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8059999942779541},{"id":"https://openalex.org/keywords/african-american-women","display_name":"African American women","score":0.8450000286102295},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7929999828338623},{"id":"https://openalex.org/keywords/breast-cancer-subtypes","display_name":"breast cancer subtypes","score":0.7749999761581421},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9190000295639038},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7409999966621399},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9179999828338623},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.7329999804496765},{"id":"https://openalex.org/keywords/stage-at-diagnosis","display_name":"stage at diagnosis","score":0.5899999737739563},{"id":"https://openalex.org/keywords/health-disparities","display_name":"health disparities","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7597392797470093},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7275489568710327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6618930101394653},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6019119024276733},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5718238353729248},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5472537875175476},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5127304792404175},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5007293224334717},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.451816588640213},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44768619537353516},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.36870110034942627},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09814730286598206},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs11-p2-14-01","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p2-14-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"},{"display_name":"Reduced inequalities","score":0.9629999995231628,"id":"https://metadata.un.org/sdg/10"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1987264721","https://openalex.org/W4205530579","https://openalex.org/W3107164600","https://openalex.org/W7160278428","https://openalex.org/W2398250083","https://openalex.org/W2735514386","https://openalex.org/W3171986080","https://openalex.org/W4322771099","https://openalex.org/W4396590485","https://openalex.org/W4313891355"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Racial":[2],"disparity":[3,106,454],"in":[4,61,429,455,470],"breast":[5,82],"cancer":[6],"(BC)":[7],"outcome":[8,131,437,456],"has":[9],"been":[10],"attributed":[11],"to":[12,14,102,247,294,388,398,472],"access":[13,471],"care,":[15],"socioeconomic":[16],"factors,":[17],"and":[18,89,98,113,130,139,149,155,159,168,173,179,194,203,215,230,243,274,329,333,340,354,358,368,405,417,431],"biologic":[19,262,464],"factors.":[20],"In":[21,70,372],"particular,":[22],"the":[23,409],"prevalence":[24],"of":[25,77,185,289,317,322,375,446,475],"triple":[26,390],"negative":[27,391],"BC":[28,141,379,392,460],"is":[29,57,123,449],"significantly":[30,276,302],"higher":[31],"among":[32,345,359,424,438,457],"African-American":[33],"(AA)":[34],"women":[35,38,76,135,187,382,413,439],"than":[36,284,393],"white":[37,202],"(non-AA).":[39],"However":[40],"a":[41,109,124,292,314],"recent":[42],"population-based":[43],"study":[44],"suggests":[45],"that":[46,59,451],"racial":[47,105,453],"disparities":[48],"persist":[49],"even":[50],"if":[51,104],"stratified":[52],"by":[53,143,303,309,435,466],"subtype,":[54],"although":[55],"it":[56],"possible":[58,450],"bias":[60],"stage":[62,80,112,213,218,377],"at":[63,220,223],"presentation":[64],"may":[65],"have":[66,324,389],"influenced":[67],"these":[68],"results.":[69],"this":[71,373,452],"study,":[72],"we":[73],"examined":[74,90],"464":[75,186],"uniform":[78],"clinical":[79,129,144,212,376],"II-III":[81,378],"cancer,":[83],"all":[84],"treated":[85],"with":[86,128,440],"neoadjuvant":[87,295],"chemotherapy,":[88],"pathologic":[91],"complete":[92],"response":[93],"(pCR),":[94],"recurrence-free":[95],"survival":[96,100],"(RFS),":[97],"overall":[99],"(OS)":[101],"see":[103],"exists":[107],"within":[108,307],"more":[110,245,386],"homogeneous":[111],"treatment":[114],"cohort.":[115],"Methods:":[116],"The":[117,170,427],"UNC":[118],"Neoadjuvant":[119],"Breast":[120],"Cancer":[121,480],"Database":[122],"prospectively":[125],"maintained":[126],"cohort":[127,374],"annotation.":[132],"We":[133],"identified":[134],"diagnosed":[136],"between":[137,166,228,338,403],"1991\u20132011":[138],"assigned":[140],"subtype":[142,308],"assay":[145],"for":[146],"estrogen":[147],"receptor":[148,151],"progesterone":[150],"(hormone":[152],"receptors,":[153],"HR)":[154],"HER2.":[156],"Fisher's":[157],"Exact":[158],"Wilcoxon":[160],"Rank":[161,175],"sum":[162],"tests":[163],"compared":[164,177],"characteristics":[165],"AA":[167,229,233,259,339,349,363,381,404,412],"non-AA.":[169],"Kaplan-Meier":[171],"method":[172],"Log":[174],"test":[176],"OS":[178,332,352,366,432],"RFS":[180,334,355,369,416,430],"curves.":[181],"Results:":[182],"142":[183],"(31%)":[184],"were":[188,192,197,205,211,234,244,383],"AA,":[189],"294":[190],"(63%)":[191],"white,":[193],"28":[195],"(6%)":[196],"other":[198],"races":[199],"(for":[200],"analysis":[201],"\u201cother\u201d":[204],"categorized":[206],"as":[207,265],"non-AA).":[208],"191":[209],"(41%)":[210],"II":[214],"273":[216],"(59%)":[217],"III":[219],"diagnosis.":[221],"Stage":[222],"diagnosis":[224],"did":[225,299,335,400],"not":[226,300,336,401],"differ":[227,301,337,402],"non-AA":[231,285,341,394,406],"(p=0.07).":[232],"slightly":[235],"older":[236],"(median":[237],"age":[238],"49":[239],"v":[240,251,271,281],"45,":[241],"p=0.01)":[242,283],"likely":[246,387],"be":[248],"HR-/Her2-":[249],"(44%":[250],"25%,":[252],"p=0.003).":[253],"All":[254],"patients":[255,290,323,347,361,461],"received":[256,260,275],"preoperative":[257],"chemotherapy.":[258],"less":[261,277],"therapy":[263,279],"such":[264],"trastuzumab":[266],"or":[267,306,442,468,473],"on-protocol":[268],"bevacizumab":[269],"(10%":[270],"18%,":[272],"p=0.03)":[273],"endocrine":[278,476],"(46%":[280],"59%,":[282],"patients.":[286,395,407],"102":[287],"(22%)":[288],"had":[291,350,364,414],"pCR":[293,297],"chemotherapy;":[296],"rates":[298],"race":[304,310],"(p=0.7)":[305],"(all":[311,342],"p>0.14).":[312],"At":[313],"median":[315],"follow-up":[316],"4.5":[318],"years,":[319],"121":[320],"(26%)":[321],"died.":[325],"Among":[326],"HR-/HER2\u2212":[327],"(n=114)":[328],"HR-/HER2+(n=47)":[330],"patients,":[331,380],"p>0.5).":[343],"Conversely,":[344],"HR+/HER2\u2212":[346],"(n=159)":[348],"worse":[351,365,415,436],"(p=0.01)":[353],"(p=":[356],"0.03)":[357],"HR+/HER2+":[360],"(n=53),":[362],"(p=0.0004)":[367],"(p=0.005).":[370],"Conclusion:":[371],"over":[384],"75%":[385],"Pathologic":[396],"reponse":[397],"chemotherapy":[399],"Examining":[408],"entire":[410],"cohort,":[411],"OS,":[418],"however":[419],"there":[420],"was":[421,433],"no":[422],"difference":[423,428],"ER-negative":[425],"subtypes.":[426],"driven":[434],"ER":[441],"PR+":[443],"tumors":[444],"(regardless":[445],"HER2).":[447],"It":[448],"hormone":[458],"receptor-positive":[459],"reflects":[462],"unknown":[463],"differences":[465,469],"race,":[467],"receipt":[474],"therapy.":[477],"Citation":[478],"Information:":[479],"Res":[481],"2011;71(24":[482],"Suppl):Abstract":[483],"nr":[484],"P2-14-01.":[485]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}